Obinutuzumab Intravenous and Suclear
Determining the interaction of Obinutuzumab Intravenous and Suclear and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Suclear, Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Obinutuzumab Intravenous-Sucralfate
- Obinutuzumab Intravenous-Sucralfate Oral Suspension
- Obinutuzumab Intravenous-Sucralfate Suspension
- Obinutuzumab Intravenous-Sucralfate Tablet
- Obinutuzumab Intravenous-Sucralfate Tablets
- Obinutuzumab Intravenous-Sucrets 4-Hour Cough Drops
- Suclear-Obizur
- Suclear-Obizur Intravenous
- Suclear-Obredon
- Suclear-Ocaliva
- Suclear-Occlucort
- Suclear-Occlusal-HP Topical